Suppr超能文献

多发性骨髓瘤及意义未明的单克隆丙种球蛋白病中的外周血淋巴细胞亚群

Peripheral blood lymphocyte subsets in multiple myeloma and monoclonal gammopathy of undetermined significance.

作者信息

Tienhaara A, Pelliniemi T T

机构信息

Department of Haematology, Turku University Central Hospital, Finland.

出版信息

Clin Lab Haematol. 1994 Sep;16(3):213-23. doi: 10.1111/j.1365-2257.1994.tb00414.x.

Abstract

Peripheral blood lymphocyte subsets were analysed by flow cytometry and compared among 43 patients with untreated multiple myeloma (MM), 16 patients with monoclonal gammopathy of undetermined significance (MGUS) and 26 controls. The age and sex distributions of the patients and controls were comparable, which is important, since in the controls there was a significant effect of age and/or sex on the number of CD3+, CD57+, CD8+57+, CD16+ and CD3-56+ lymphocyte subsets, and on the CD4+/CD8+ and CD4+Leu-8+/CD4+ ratios. In MM, the number of CD8+ and CD57+ cells and the CD4+/CD8+ ratio were related to the clinical stage. The number of CD20+, CD3+, CD4+, CD16+ and CD3-56+ cells and the CD3+/CD20+ ratio were significantly different in MM patients compared to age- and sex-matched controls as was the number of CD3+ and CD4+ cells of MGUS patients compared to controls. Further, there were significant differences in the CD3+/CD20+ ratio between MM and MGUS patients and between stage I MM and MGUS. The role of peripheral blood lymphocyte subsets in differentiating monoclonal gammopathies merits further study.

摘要

采用流式细胞术分析外周血淋巴细胞亚群,并在43例未经治疗的多发性骨髓瘤(MM)患者、16例意义未明的单克隆丙种球蛋白病(MGUS)患者和26例对照者之间进行比较。患者和对照者的年龄和性别分布具有可比性,这一点很重要,因为在对照者中,年龄和/或性别对CD3⁺、CD57⁺、CD8⁺57⁺、CD16⁺和CD3⁻56⁺淋巴细胞亚群的数量以及CD4⁺/CD8⁺和CD4⁺Leu-8⁺/CD4⁺比值有显著影响。在MM中,CD8⁺和CD57⁺细胞的数量以及CD4⁺/CD8⁺比值与临床分期相关。与年龄和性别匹配的对照者相比,MM患者的CD20⁺、CD3⁺、CD4⁺、CD16⁺和CD3⁻56⁺细胞数量以及CD3⁺/CD20⁺比值有显著差异,MGUS患者的CD3⁺和CD4⁺细胞数量与对照者相比也有显著差异。此外,MM与MGUS患者之间以及I期MM与MGUS之间的CD3⁺/CD20⁺比值存在显著差异。外周血淋巴细胞亚群在鉴别单克隆丙种球蛋白病中的作用值得进一步研究。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验